Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Harvard Bioscience, Inc./ DEFA14A

SEC Filing · DEFA14A

Harvard Bioscience, Inc.

HBIONASDAQEQUITYCurrent

SEC Filing

Filed Apr 21, 2026Accepted Apr 21, 2026, 4:58 PM EDTCIK 1123494Accession 0001171843-26-002623
View company →Permanent SEC source ↗
Share

Company context

Current securities

HBIONASDAQ · EQUITY · Current

Recent company filings

  1. 10-Q filingAug 11, 2026
  2. Regulation FD DisclosureAug 11, 2026
  3. Results of Operations and Financial ConditionAug 11, 2026
  4. S-8 filingJun 10, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security HoldersJun 2, 2026

As-filed source

Primary evidence
As filedOpen full document ↗